Kymera Therapeutics (KYMR) Nyalo Cwiny me Stock
Lich me gik$112.02Oyiko 25 Sep 2026 19:59 UTC
Loko-3.27%
AI forecast: KYMR
AI otyeko kwena ya ceng ma lwenyo, gima agik juma, ki gima agik juma. Kwena en gima iyar ki neno kwena ma nyaka. Gin en neno ki kare, onyo nyutu ya yat.
Jaji e lweny e dwe 6 mag giko
Premium nyalo neno ceng'a AI me yweyo piyo ki 1 odiiyo, 1 juma ki 1 dwe ki gima onongo ki gikato ma okato.
Unlock Premium🔒 Nyinge yoo oryeto
Neno kare duto — forecast duto ma otyeko ki kwena ma otyeko — en pake Premium.
Unlock PremiumNyinge Aciya Man
Kymera Therapeutics, Inc. operates as a biopharmaceutical company focused on discovering and developing novel small-molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body’s natural protein degradation machinery. Kymera Therapeutics serves customers in Massachusetts.
